Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Mehler-Wex

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|November 22, 2005
[Encopresis--predictive factors and outcome]Claudia Mehler-Wex, Peter Scheuerpflug, Nicole Peschke, et al.
Journal of Child and Adolescent Psychopharmacology|December 29, 2005
Olanzapine overdose in children and adolescents: two case reports and a review of the literatureFrank M Theisen, Justyna Grabarkiewicz, Christine Fegbeutel, et al.
Child and Adolescent Psychiatry and Mental Health|April 11, 2009
Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapyClaudia Mehler-Wex, Michael Kölch, Julia Kirchheiner, et al.
Therapeutic Drug Monitoring|January 16, 2013
The relation between dosage, serum concentrations, and clinical outcome in children and adolescents treated with sertraline: a naturalistic studyRegina Taurines, Rainer Burger, Christoph Wewetzer, et al.
European Child & Adolescent Psychiatry|June 22, 2006
Increased mRNA levels of the mitochondrial complex I 75-kDa subunit. A potential peripheral marker of early onset schizophrenia?Claudia Mehler-Wex, J Catharina Duvigneau, Romana T Hartl, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|February 21, 2006
[Therapeutic drug monitoring in child and adolescent psychiatry--practical recommendations]Manfred Gerlach, Silke Rothenhöfer, Claudia Mehler-Wex, et al.
Expert Opinion on Drug Safety|August 24, 2016
Therapeutic drug monitoring as a measure of proactive pharmacovigilance in child and adolescent psychiatryManfred Gerlach, Karin Egberts, Su-Yin Dang, et al.
Journal of Psychiatry & Neuroscience : JPN|December 31, 2009
Structural abnormality of the substantia nigra in children with attention-deficit hyperactivity disorderMarcel Romanos, David Weise, Mira Schliesser, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|November 14, 2018
[Polypharmacy of psychotropic drugs in child and adolescent psychiatry in Germany - rather the rule than the exception]Timo D Vloet, Karin Egberts, Regina Taurines, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|December 25, 2014
[Pharmacovigilance in child and adolescent psychiatry]Karin Egberts, Andreas Karwautz, Paul L Plener, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|November 22, 2005
[Encopresis--predictive factors and outcome]Claudia Mehler-Wex, Peter Scheuerpflug, Nicole Peschke, et al.
Journal of Child and Adolescent Psychopharmacology|December 29, 2005
Olanzapine overdose in children and adolescents: two case reports and a review of the literatureFrank M Theisen, Justyna Grabarkiewicz, Christine Fegbeutel, et al.
Child and Adolescent Psychiatry and Mental Health|April 11, 2009
Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapyClaudia Mehler-Wex, Michael Kölch, Julia Kirchheiner, et al.
Therapeutic Drug Monitoring|January 16, 2013
The relation between dosage, serum concentrations, and clinical outcome in children and adolescents treated with sertraline: a naturalistic studyRegina Taurines, Rainer Burger, Christoph Wewetzer, et al.
European Child & Adolescent Psychiatry|June 22, 2006
Increased mRNA levels of the mitochondrial complex I 75-kDa subunit. A potential peripheral marker of early onset schizophrenia?Claudia Mehler-Wex, J Catharina Duvigneau, Romana T Hartl, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|February 21, 2006
[Therapeutic drug monitoring in child and adolescent psychiatry--practical recommendations]Manfred Gerlach, Silke Rothenhöfer, Claudia Mehler-Wex, et al.
Expert Opinion on Drug Safety|August 24, 2016
Therapeutic drug monitoring as a measure of proactive pharmacovigilance in child and adolescent psychiatryManfred Gerlach, Karin Egberts, Su-Yin Dang, et al.
Journal of Psychiatry & Neuroscience : JPN|December 31, 2009
Structural abnormality of the substantia nigra in children with attention-deficit hyperactivity disorderMarcel Romanos, David Weise, Mira Schliesser, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|November 14, 2018
[Polypharmacy of psychotropic drugs in child and adolescent psychiatry in Germany - rather the rule than the exception]Timo D Vloet, Karin Egberts, Regina Taurines, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|December 25, 2014
[Pharmacovigilance in child and adolescent psychiatry]Karin Egberts, Andreas Karwautz, Paul L Plener, et al.
Pageof 4